Sarcopenia in daily practice: assessment and management

Charlotte Beaudart, Eugène McCloskey, Olivier Bruyère, Matteo Cesari, Yves Rolland, René Rizzoli, Islène Araujo de Carvalho, Jotheeswaran Amuthavalli Thiyagarajan, Ivan Bautmans, Marie Claude Bertière, Maria Luisa Brandi, Nasser M. Al-Daghri, Nansa Burlet, Etienne Cavalier, Francesca Cerreta, Antonio Cherubini, Roger Fielding, Evelien Gielen, Francesco Landi, Jean PetermansJean Yves Reginster, Marjolein Visser, John Kanis, Cyrus Cooper

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Background: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice. Methods: This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations. Results: This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress. Conclusions: Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalBMC Geriatrics
Volume16
Issue number1
DOIs
Publication statusPublished - 2016

Fingerprint

Sarcopenia
Practice Management
Muscle Strength
Health Personnel
Primary Health Care
Clinical Trials
Pharmacology
Muscles
Mortality

Keywords

  • Assessment
  • Daily practice
  • Management
  • Sarcopenia
  • Tools

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Beaudart, C., McCloskey, E., Bruyère, O., Cesari, M., Rolland, Y., Rizzoli, R., ... Cooper, C. (2016). Sarcopenia in daily practice: assessment and management. BMC Geriatrics, 16(1), 1-10. https://doi.org/10.1186/s12877-016-0349-4

Sarcopenia in daily practice : assessment and management. / Beaudart, Charlotte; McCloskey, Eugène; Bruyère, Olivier; Cesari, Matteo; Rolland, Yves; Rizzoli, René; Araujo de Carvalho, Islène; Amuthavalli Thiyagarajan, Jotheeswaran; Bautmans, Ivan; Bertière, Marie Claude; Brandi, Maria Luisa; Al-Daghri, Nasser M.; Burlet, Nansa; Cavalier, Etienne; Cerreta, Francesca; Cherubini, Antonio; Fielding, Roger; Gielen, Evelien; Landi, Francesco; Petermans, Jean; Reginster, Jean Yves; Visser, Marjolein; Kanis, John; Cooper, Cyrus.

In: BMC Geriatrics, Vol. 16, No. 1, 2016, p. 1-10.

Research output: Contribution to journalArticle

Beaudart, C, McCloskey, E, Bruyère, O, Cesari, M, Rolland, Y, Rizzoli, R, Araujo de Carvalho, I, Amuthavalli Thiyagarajan, J, Bautmans, I, Bertière, MC, Brandi, ML, Al-Daghri, NM, Burlet, N, Cavalier, E, Cerreta, F, Cherubini, A, Fielding, R, Gielen, E, Landi, F, Petermans, J, Reginster, JY, Visser, M, Kanis, J & Cooper, C 2016, 'Sarcopenia in daily practice: assessment and management', BMC Geriatrics, vol. 16, no. 1, pp. 1-10. https://doi.org/10.1186/s12877-016-0349-4
Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R et al. Sarcopenia in daily practice: assessment and management. BMC Geriatrics. 2016;16(1):1-10. https://doi.org/10.1186/s12877-016-0349-4
Beaudart, Charlotte ; McCloskey, Eugène ; Bruyère, Olivier ; Cesari, Matteo ; Rolland, Yves ; Rizzoli, René ; Araujo de Carvalho, Islène ; Amuthavalli Thiyagarajan, Jotheeswaran ; Bautmans, Ivan ; Bertière, Marie Claude ; Brandi, Maria Luisa ; Al-Daghri, Nasser M. ; Burlet, Nansa ; Cavalier, Etienne ; Cerreta, Francesca ; Cherubini, Antonio ; Fielding, Roger ; Gielen, Evelien ; Landi, Francesco ; Petermans, Jean ; Reginster, Jean Yves ; Visser, Marjolein ; Kanis, John ; Cooper, Cyrus. / Sarcopenia in daily practice : assessment and management. In: BMC Geriatrics. 2016 ; Vol. 16, No. 1. pp. 1-10.
@article{d0ca63a82c984d47a4dd256c22261ac2,
title = "Sarcopenia in daily practice: assessment and management",
abstract = "Background: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice. Methods: This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations. Results: This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress. Conclusions: Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future.",
keywords = "Assessment, Daily practice, Management, Sarcopenia, Tools",
author = "Charlotte Beaudart and Eug{\`e}ne McCloskey and Olivier Bruy{\`e}re and Matteo Cesari and Yves Rolland and Ren{\'e} Rizzoli and {Araujo de Carvalho}, Isl{\`e}ne and {Amuthavalli Thiyagarajan}, Jotheeswaran and Ivan Bautmans and Berti{\`e}re, {Marie Claude} and Brandi, {Maria Luisa} and Al-Daghri, {Nasser M.} and Nansa Burlet and Etienne Cavalier and Francesca Cerreta and Antonio Cherubini and Roger Fielding and Evelien Gielen and Francesco Landi and Jean Petermans and Reginster, {Jean Yves} and Marjolein Visser and John Kanis and Cyrus Cooper",
year = "2016",
doi = "10.1186/s12877-016-0349-4",
language = "English",
volume = "16",
pages = "1--10",
journal = "BMC Geriatrics",
issn = "1471-2318",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Sarcopenia in daily practice

T2 - assessment and management

AU - Beaudart, Charlotte

AU - McCloskey, Eugène

AU - Bruyère, Olivier

AU - Cesari, Matteo

AU - Rolland, Yves

AU - Rizzoli, René

AU - Araujo de Carvalho, Islène

AU - Amuthavalli Thiyagarajan, Jotheeswaran

AU - Bautmans, Ivan

AU - Bertière, Marie Claude

AU - Brandi, Maria Luisa

AU - Al-Daghri, Nasser M.

AU - Burlet, Nansa

AU - Cavalier, Etienne

AU - Cerreta, Francesca

AU - Cherubini, Antonio

AU - Fielding, Roger

AU - Gielen, Evelien

AU - Landi, Francesco

AU - Petermans, Jean

AU - Reginster, Jean Yves

AU - Visser, Marjolein

AU - Kanis, John

AU - Cooper, Cyrus

PY - 2016

Y1 - 2016

N2 - Background: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice. Methods: This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations. Results: This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress. Conclusions: Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future.

AB - Background: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice. Methods: This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations. Results: This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress. Conclusions: Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future.

KW - Assessment

KW - Daily practice

KW - Management

KW - Sarcopenia

KW - Tools

UR - http://www.scopus.com/inward/record.url?scp=84992052960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992052960&partnerID=8YFLogxK

U2 - 10.1186/s12877-016-0349-4

DO - 10.1186/s12877-016-0349-4

M3 - Article

AN - SCOPUS:84992052960

VL - 16

SP - 1

EP - 10

JO - BMC Geriatrics

JF - BMC Geriatrics

SN - 1471-2318

IS - 1

ER -